NORA — Nootropics Research Alliance
Nootropics with a named mechanism and a cited trial. Or we don't ship them.
We're a research alliance for people who can't afford an off day — not a supplement brand. Every release ships with a mechanism we can name and a study we can cite, starting with NeuroDrive, a single, named compound evaluated against exactly that standard.
What we're building
NORA isn't a single-product storefront — it's the early shelf of a research-led catalog we're building release by release. Every addition gets evaluated the same way NeuroDrive was: a mechanism we can name, a study we can cite, or it doesn't make the cut.
RELEASE 01
NeuroDrive
Sublingual bromantane, one named mechanism — evaluated against the standard above, not an exception to it.
View NeuroDrive →RELEASE 02
In research
RELEASE 03
In research
The two methods
One method compounds. The other just trends.
NORA — RESEARCH-LED
Every release names a mechanism and cites a study. If it doesn't hold up, we don't ship it — no matter how well it would sell.
INDUSTRY — HYPE-LED
Proprietary blends nobody can verify, reviews standing in for clinical evidence, a compound chosen because it's trending this quarter.
Mission
NeuroDrive is proof of the standard, not an exception to it — every product that follows gets evaluated the same way.
Mechanism over marketing
Every claim traces back to a pathway we can name and a study we can cite. No proprietary fairy dust.
Built for skeptics
You've tried things that didn't work. Good — that's the right instinct. We'd rather you read the research than take our word for it.
Curated, not exhaustive
We'd rather release one compound we trust completely than fifty we're unsure about. Every addition to the catalog has to earn its place.